7575 Japan Lifeline
- 1161
- -17-1.44%
Japan Lifeline News
Japan Lifeline: Japan Lifeline Launches Wallaby Medical’s Stent Retriever
Japan Lifeline: Notice regarding the start of sales of stent retrievers
Japan Lifeline: Japan Lifeline Announces Changes in Organization and Personnel
Japan Lifeline: Notice regarding organizational changes and personnel changes
Japan Lifeline: Consolidated financial results for the three months ending on June 30, 2024 [Japanese standards]
Japan Lifeline: Japan Lifeline announced the completion of payment for the disposal of treasury stocks as a restricted stock incentive plan for ESA and partial confiscation.
Japan Lifeline: Corporate Governance Report June 28, 2024.
Japan Lifeline: Japan Lifeline has released an overview of the effectiveness of its board of directors' evaluation.
Japan Lifeline: Overview of evaluation results regarding the effectiveness of the board of directors.
Japan Lifeline: Independent Company Executives Declaration
Japan Lifeline: Japan Lifeline will release an updated version of the sponsor research reports.
Japan Lifeline: Announcements of individual stocks were issued in the sponsored report.
Japan Lifeline: Japan Lifeline announces the results of the public tender offer for its own shares and changes in major shareholders and principal shareholders.
Japan Lifeline: Announcements of individual stock: Results of the tender offer for own shares, completion of acquisition of own shares, and change of major shareholder who is the largest shareholder.
Japan Lifeline: Japan Lifeline announces organizational and personnel changes
Japan Lifeline: Japan Lifeline Announces Dividends from Surplus Funds for the Fiscal Year Ending 2024/3
Japan Lifeline: Notice regarding organizational changes and personnel changes
Japan Lifeline: Consolidated financial results for the year ended 2024/3/31 [Japanese GAAP]
Japan Lifeline: Japan Lifeline announces share acquisition and tender offer for treasury stock
Japan Lifeline: Japan Lifeline announces changes to the board of directors
Analysis
Price Target
No Data
